ECM
PDSB icon

Element Capital Management’s PDS Biotechnology PDSB Stock Holding History

Element Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,933
Closed -$32K – 826
2018
Q3 		$32K Sell
1,933
-3,480
-64% -$62.5K ﹤0.01% 874
2018
Q2 		$112K Sell
5,413
-98
-2% -$2.04K ﹤0.01% 786
2018
Q1 		$130K Buy
+5,511
New +$1.48M ﹤0.01% 760

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Element Capital Management's PDSB Position: Q4 2018 in Review

Element Capital Management sold out of PDS Biotechnology (PDSB) in Q4 2018, closing a stake of 1,933 shares — an estimated $32K sold.

Element Capital Management first reported a position in PDSB in Q1 2018 and held it in 3 quarters. The position peaked at $130K in Q1 2018. 31 funds tracked by Wall St. Rank hold PDSB as of Q4 2018.

  • Element Capital Management reported no remaining PDS Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 1,933 PDS Biotechnology shares in Q4 2018, an estimated $32K.
  • Element Capital Management first reported a position in PDS Biotechnology in Q1 2018 and held it in 3 quarters.
  • Element Capital Management's PDS Biotechnology position peaked at $130K in Q1 2018.
  • 31 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.